Dynavax Net Income From Continuing Ops vs Reconciled Depreciation Analysis

DVAX Stock

USD 11.21 0.04 0.36%

Dynavax Technologies financial indicator trend analysis is much more than just examining Dynavax Technologies latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dynavax Technologies is a good investment. Please check the relationship between Dynavax Technologies Net Income From Continuing Ops and its Reconciled Depreciation accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Net Income From Continuing Ops vs Reconciled Depreciation

Net Income From Continuing Ops vs Reconciled Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dynavax Technologies Net Income From Continuing Ops account and Reconciled Depreciation. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Dynavax Technologies' Net Income From Continuing Ops and Reconciled Depreciation is -0.24. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Dynavax Technologies, assuming nothing else is changed. The correlation between historical values of Dynavax Technologies' Net Income From Continuing Ops and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Dynavax Technologies are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Net Income From Continuing Ops i.e., Dynavax Technologies' Net Income From Continuing Ops and Reconciled Depreciation go up and down completely randomly.

Correlation Coefficient

-0.24

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Income From Continuing Ops

Reconciled Depreciation

Most indicators from Dynavax Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dynavax Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.At this time, Dynavax Technologies' Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 95.41 in 2024, whereas Tax Provision is likely to drop slightly above 945.2 K in 2024.

	2023	2024 (projected)
Interest Income	26.8M	28.1M
Non Recurring	15.4M	16.1M

Interest Income Non Recurring

Dynavax Technologies fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Accounts Payable	Cash	Short Term Investments	Other Current Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Property Plant And Equipment Gross	Total Current Assets	Net Receivables
Total Assets		0.85	-0.49	-0.22	0.93	0.81	0.86	0.56	0.61	0.13	0.83	0.8	-0.06	0.19	0.91	0.92	0.62	0.11	0.84	0.74	0.97	0.22	0.87	0.88	0.97	0.84
Total Stockholder Equity	0.85		-0.21	-0.24	0.74	0.67	0.48	0.17	0.17	0.04	0.49	0.96	0.37	0.21	0.61	0.71	0.2	0.18	0.48	0.36	0.94	0.25	0.65	0.74	0.93	0.59
Retained Earnings	-0.49	-0.21		0.48	-0.73	-0.87	-0.63	-0.48	-0.46	-0.67	-0.45	-0.26	0.26	0.02	-0.74	-0.7	-0.39	-0.36	-0.57	-0.49	-0.39	0.01	-0.6	-0.64	-0.41	-0.41
Other Assets	-0.22	-0.24	0.48		-0.25	-0.49	-0.14	-0.15	-0.18	-0.27	-0.21	-0.2	0.08	-0.41	-0.28	-0.22	-0.16	0.08	-0.18	-0.16	-0.22	-0.41	0.01	-0.19	-0.21	-0.14
Common Stock Shares Outstanding	0.93	0.74	-0.73	-0.25		0.93	0.86	0.58	0.56	0.33	0.74	0.73	-0.02	0.08	0.94	0.98	0.53	0.32	0.83	0.72	0.87	0.11	0.91	0.91	0.88	0.8
Other Stockholder Equity	0.81	0.67	-0.87	-0.49	0.93		0.72	0.44	0.43	0.53	0.59	0.69	-0.02	0.08	0.88	0.89	0.4	0.37	0.67	0.55	0.77	0.11	0.79	0.87	0.79	0.6
Total Liab	0.86	0.48	-0.63	-0.14	0.86	0.72		0.78	0.87	0.19	0.93	0.43	-0.45	0.12	0.95	0.86	0.85	0.01	0.95	0.9	0.73	0.13	0.85	0.77	0.75	0.84
Other Current Liab	0.56	0.17	-0.48	-0.15	0.58	0.44	0.78		0.9	0.04	0.84	0.0	-0.41	0.06	0.65	0.53	0.82	-0.34	0.91	0.96	0.38	0.05	0.43	0.31	0.36	0.87
Total Current Liabilities	0.61	0.17	-0.46	-0.18	0.56	0.43	0.87	0.9		-0.04	0.93	0.03	-0.71	0.13	0.73	0.55	0.99	-0.44	0.9	0.93	0.44	0.13	0.47	0.38	0.43	0.77
Accounts Payable	0.13	0.04	-0.67	-0.27	0.33	0.53	0.19	0.04	-0.04		-0.01	0.17	0.05	-0.08	0.36	0.28	-0.1	0.54	0.08	0.02	0.12	-0.06	0.35	0.43	0.14	-0.03
Cash	0.83	0.49	-0.45	-0.21	0.74	0.59	0.93	0.84	0.93	-0.01		0.36	-0.48	0.12	0.85	0.71	0.93	-0.34	0.95	0.94	0.72	0.13	0.65	0.58	0.7	0.88
Short Term Investments	0.8	0.96	-0.26	-0.2	0.73	0.69	0.43	0.0	0.03	0.17	0.36		0.4	0.2	0.59	0.72	0.07	0.4	0.36	0.22	0.91	0.24	0.71	0.81	0.91	0.44
Other Current Assets	-0.06	0.37	0.26	0.08	-0.02	-0.02	-0.45	-0.41	-0.71	0.05	-0.48	0.4		-0.03	-0.32	-0.07	-0.74	0.47	-0.36	-0.42	0.09	-0.02	-0.05	0.0	0.08	-0.11
Common Stock	0.19	0.21	0.02	-0.41	0.08	0.08	0.12	0.06	0.13	-0.08	0.12	0.2	-0.03		0.09	0.12	0.15	-0.01	0.15	0.15	0.2	1.0	0.01	0.09	0.19	0.19
Property Plant Equipment	0.91	0.61	-0.74	-0.28	0.94	0.88	0.95	0.65	0.73	0.36	0.85	0.59	-0.32	0.09		0.93	0.72	0.15	0.88	0.79	0.82	0.11	0.89	0.89	0.83	0.77
Property Plant And Equipment Net	0.92	0.71	-0.7	-0.22	0.98	0.89	0.86	0.53	0.55	0.28	0.71	0.72	-0.07	0.12	0.93		0.54	0.37	0.81	0.69	0.85	0.15	0.93	0.94	0.87	0.76
Current Deferred Revenue	0.62	0.2	-0.39	-0.16	0.53	0.4	0.85	0.82	0.99	-0.1	0.93	0.07	-0.74	0.15	0.72	0.54		-0.47	0.86	0.89	0.47	0.16	0.47	0.38	0.46	0.73
Net Debt	0.11	0.18	-0.36	0.08	0.32	0.37	0.01	-0.34	-0.44	0.54	-0.34	0.4	0.47	-0.01	0.15	0.37	-0.47		-0.13	-0.27	0.15	0.01	0.47	0.51	0.2	-0.14
Non Current Assets Total	0.84	0.48	-0.57	-0.18	0.83	0.67	0.95	0.91	0.9	0.08	0.95	0.36	-0.36	0.15	0.88	0.81	0.86	-0.13		0.98	0.69	0.16	0.73	0.65	0.69	0.95
Non Currrent Assets Other	0.74	0.36	-0.49	-0.16	0.72	0.55	0.9	0.96	0.93	0.02	0.94	0.22	-0.42	0.15	0.79	0.69	0.89	-0.27	0.98		0.58	0.16	0.6	0.51	0.57	0.94
Cash And Short Term Investments	0.97	0.94	-0.39	-0.22	0.87	0.77	0.73	0.38	0.44	0.12	0.72	0.91	0.09	0.2	0.82	0.85	0.47	0.15	0.69	0.58		0.23	0.82	0.86	1.0	0.72
Common Stock Total Equity	0.22	0.25	0.01	-0.41	0.11	0.11	0.13	0.05	0.13	-0.06	0.13	0.24	-0.02	1.0	0.11	0.15	0.16	0.01	0.16	0.16	0.23		0.04	0.12	0.22	0.19
Non Current Liabilities Total	0.87	0.65	-0.6	0.01	0.91	0.79	0.85	0.43	0.47	0.35	0.65	0.71	-0.05	0.01	0.89	0.93	0.47	0.47	0.73	0.6	0.82	0.04		0.96	0.85	0.67
Property Plant And Equipment Gross	0.88	0.74	-0.64	-0.19	0.91	0.87	0.77	0.31	0.38	0.43	0.58	0.81	0.0	0.09	0.89	0.94	0.38	0.51	0.65	0.51	0.86	0.12	0.96		0.89	0.59
Total Current Assets	0.97	0.93	-0.41	-0.21	0.88	0.79	0.75	0.36	0.43	0.14	0.7	0.91	0.08	0.19	0.83	0.87	0.46	0.2	0.69	0.57	1.0	0.22	0.85	0.89		0.71
Net Receivables	0.84	0.59	-0.41	-0.14	0.8	0.6	0.84	0.87	0.77	-0.03	0.88	0.44	-0.11	0.19	0.77	0.76	0.73	-0.14	0.95	0.94	0.72	0.19	0.67	0.59	0.71

Click cells to compare fundamentals

Dynavax Technologies Account Relationship Matchups

Dynavax Technologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	279.1M	353.3M	1.0B	985.9M	997.1M	1.0B
Total Stockholder Equity	8.3M	58.7M	222.4M	581.0M	622.1M	653.2M
Retained Earnings	(1.2B)	(1.3B)	(1.2B)	(924.2M)	(930.6M)	(884.1M)
Other Assets	3.6M	3.8M	368.9K	3.5M	3.2M	3.0M
Common Stock Shares Outstanding	72.0M	100.8M	133.0M	150.8M	128.7M	135.2M
Liabilities And Stockholders Equity	279.1M	353.3M	1.0B	985.9M	997.1M	1.0B
Other Stockholder Equity	1.2B	1.4B	1.4B	1.5B	1.6B	1.6B
Total Liab	270.8M	294.6M	816.9M	404.8M	375.0M	393.8M
Other Current Liab	43.8M	32.6M	201.4M	143.2M	24K	22.8K
Total Current Liabilities	53.0M	77.4M	556.4M	150.1M	62.2M	58.2M
Accounts Payable	9.3M	3.3M	2.6M	3.2M	5.2M	3.1M
Cash	39.9M	32.1M	436.2M	202.0M	150.3M	157.8M
Short Term Investments	111.2M	133.0M	109.8M	422.4M	592.0M	621.6M
Other Current Assets	(8.9M)	(22.7M)	(131.8M)	85.6M	19.0M	19.9M
Common Stock	84K	110K	123K	128K	130K	83.9K
Property Plant Equipment	32.0M	30.6M	61.0M	37.6M	43.2M	45.4M
Property Plant And Equipment Net	32.0M	57.2M	61.0M	63.3M	61.6M	64.7M
Net Debt	176.6M	185.8M	(178.8M)	56.0M	106.6M	112.0M
Non Current Assets Total	86.7M	124.5M	432.0M	302.0M	138.0M	144.9M
Non Currrent Assets Other	50.1M	65.1M	368.9M	236.7M	74.3M	46.9M
Cash And Short Term Investments	151.1M	165.0M	546.0M	624.4M	742.3M	779.4M
Common Stock Total Equity	84K	110K	123K	128K	147.2K	85.0K
Non Current Liabilities Total	217.7M	217.2M	260.5M	254.8M	312.8M	328.5M
Property Plant And Equipment Gross	62.3M	57.2M	61.0M	63.3M	93.4M	98.1M
Total Current Assets	192.4M	228.7M	607.3M	683.8M	859.1M	902.1M
Accumulated Other Comprehensive Income	(2.4M)	273K	(2.3M)	(5.4M)	(2.1M)	(2.2M)
Net Receivables	8.9M	22.7M	131.8M	147.5M	44.5M	46.8M
Other Liab	1.3M	2.6M	5.7M	384K	345.6K	328.3K
Good Will	2.1M	2.3M	2.1M	2.0M	2.1M	1.8M
Inventory	41.3M	63.7M	61.3M	59.4M	53.3M	56.0M
Short Long Term Debt Total	216.4M	217.8M	257.4M	258.0M	256.9M	148.6M
Long Term Debt	178.6M	179.8M	220.5M	221.6M	222.7M	233.8M
Net Tangible Assets	3.7M	56.4M	220.2M	579.0M	665.9M	699.2M
Retained Earnings Total Equity	(1.2B)	(1.3B)	(1.2B)	(924.2M)	(831.8M)	(873.4M)
Capital Surpluse	1.2B	1.4B	1.4B	1.5B	1.7B	1.1B
Non Current Liabilities Other	39.1M	37.4M	5.7M	33.2M	74K	70.3K

Pair Trading with Dynavax Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.

Moving against Dynavax Stock

0.65	ACB	Aurora Cannabis Sell-off Trend	Pair Corr
0.59	ELYM	Eliem Therapeutics Upward Rally	Pair Corr
0.55	CGC	Canopy Growth Corp Financial Report 27th of June 2024	Pair Corr
0.5	HCWB	HCW Biologics	Pair Corr
0.46	KRYS	Krystal Biotech Financial Report 13th of May 2024	Pair Corr

The ability to find closely correlated positions to Dynavax Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dynavax Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dynavax Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dynavax Technologies to buy it.

The correlation of Dynavax Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dynavax Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dynavax Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Dynavax Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Dynavax Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dynavax Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dynavax Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dynavax Technologies Stock:

How To Invest In Dynavax

Details

Is Dynavax Stock a good investment?

Details

What is Dynavax Technologies' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Dynavax Stock analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Stocks Directory Find actively traded stocks across global markets
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges

Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.77)

Earnings Share

(0.05)

Revenue Per Share

1.804

Quarterly Revenue Growth

(0.70)

Return On Assets

(0.02)

The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dynavax Net Income From Continuing Ops vs Reconciled Depreciation Analysis

Net Income From Continuing Ops vs Reconciled Depreciation

Net Income From Continuing Ops vs Reconciled Depreciation Correlation Analysis

Correlation Coefficient

Net Income From Continuing Ops

Reconciled Depreciation

Dynavax Technologies fundamental ratios Correlations

Dynavax Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dynavax Technologies fundamental ratios Accounts

Pair Trading with Dynavax Technologies

Moving against Dynavax Stock

Complementary Tools for Dynavax Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Common Stock
Total Current Assets	+ 1.0	Cash And Short Term Investments
Current Deferred Revenue	+ 0.99	Total Current Liabilities
Property Plant And Equipment Net	+ 0.98	Common Stock Shares Outstanding
Non Currrent Assets Other	+ 0.98	Non Current Assets Total
Cash And Short Term Investments	+ 0.97	Total Assets

Other Stockholder Equity	- 0.87	Retained Earnings
Current Deferred Revenue	- 0.74	Other Current Assets
Property Plant Equipment	- 0.74	Retained Earnings
Common Stock Shares Outstanding	- 0.73	Retained Earnings
Other Current Assets	- 0.71	Total Current Liabilities
Property Plant And Equipment Net	- 0.7	Retained Earnings